CoChat

Integrase residues that determine nucleotide preferences at sites of HIV-1 integration: implications for the mechanism of target DNA binding

Open access

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Abstract

Retroviruses favor target-DNA (tDNA) distortion and particular bases at sites of integration, but the mechanism underlying HIV-1 selectivity is unknown. Crystal structures revealed a network of prototype foamy virus (PFV) integrase residues that distort tDNA: Ala188 and Arg329 interact with tDNA bases, while Arg362 contacts the phosphodiester backbone. HIV-1 integrase residues Ser119, Arg231, and Lys258 were identified here as analogs of PFV integrase residues Ala188, Arg329 and Arg362, respectively. Thirteen integrase mutations were analyzed for effects on integrase activity in vitro and during virus infection, yielding a total of 1610 unique HIV-1 integration sites. Purine (R)/pyrimidine (Y) dinucleotide sequence analysis revealed HIV-1 prefers the tDNA signature (0)RYXRY(4), which accordingly favors overlapping flexible dinucleotides at the center of the integration site. Consistent with roles for Arg231 and Lys258 in sequence specific and non-specific binding, respectively, the R231E mutation altered integration site nucleotide preferences while K258E had no effect. S119A and S119T integrase mutations significantly altered base preferences at positions -3 and 7 from the site of viral DNA joining. The S119A preference moreover mimicked wild-type PFV selectivity at these positions. We conclude that HIV-1 IN residue Ser119 and PFV IN residue Ala188 contact analogous tDNA bases to effect virus integration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gku136

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. PFV and HIV-1 IN sequence alignments. (A) Structure-based amino acid sequence alignment of IN CCDs with secondary elements (α and β represent α helix and β strand, respectively) noted atop the sequences. PFV assignments (upper) are from protein database (PDB) code 3OY9, whereas the HIV-1 elements (lower) are from reference (27). (B) Sequence alignment of IN CTDs. PFV IN residues Ala188, Arg329 and Arg362 in panels (A) and (B) are highlighted in yellow and underlined. HIV-1 IN residues targeted for mutagenesis are underlined and highlighted in red. Positions of amino acid identity are marked by asterisk, while colons mark positions of chemical similarity.
Figure 1. PFV and HIV-1 IN sequence alignments. (A) Structure-based amino acid sequence alignment of IN CCDs with secondary elements (α and β represent α helix and β strand, respectively) noted atop the sequences. PFV assignments (upper) are from protein database (PDB) code 3OY9, whereas the HIV-1 elements (lower) are from reference (27). (B) Sequence alignment of IN CTDs. PFV IN residues Ala188, Arg329 and Arg362 in panels (A) and (B) are highlighted in yellow and underlined. HIV-1 IN residues targeted for mutagenesis are underlined and highlighted in red. Positions of amino acid identity are marked by asterisk, while colons mark positions of chemical similarity.CC BY-NC · PubMed Central
Figure 2. HIV-1 IN 3′-processing and DNA-strand-transfer substrate design and enzyme activities. (A) Substrate cartoons are shown to highlight the different U5 DNA +strand termini and positions of radiolabel (*). The vertical arrow and underline in the 3′-processing substrate mark the scissile phosphodiester bond and cleaved pGTOH dinucleotide, respectively. (B) IN mutant 3′-processing (black) and strand-transfer (gray) activities expressed as percentages of WT IN function. Results are averages ± standard deviation (SD) for three experimental replicates. Paired analyses revealed mutant activities that differed significantly from the WT (*P < 0.05; **P < 0.01) as well as individual mutant IN strand-transfer activities that differed significantly from the level of 3′-processing activity (asterisks above brackets).
Figure 2. HIV-1 IN 3′-processing and DNA-strand-transfer substrate design and enzyme activities. (A) Substrate cartoons are shown to highlight the different U5 DNA +strand termini and positions of radiolabel (*). The vertical arrow and underline in the 3′-processing substrate mark the scissile phosphodiester bond and cleaved pGTOH dinucleotide, respectively. (B) IN mutant 3′-processing (black) and strand-transfer (gray) activities expressed as percentages of WT IN function. Results are averages ± standard deviation (SD) for three experimental replicates. Paired analyses revealed mutant activities that differed significantly from the WT (*P < 0.05; **P < 0.01) as well as individual mutant IN strand-transfer activities that differed significantly from the level of 3′-processing activity (asterisks above brackets).CC BY-NC · PubMed Central
Figure 3. Concerted vDNA integration activities of HIV-1 IN proteins. (A) The agarose gel image highlights migration positions of the pre-processed 32-bp vDNA substrate, supercoiled (s.c.) and open circular (o.c.) forms of pGEM-3 tDNA, as well as products of half-site and concerted vDNA integration. The reactions loaded in lanes 1 and 18 omitted IN protein; LEDGF/p75 was included in each set of reactions as indicated. (B) Results (average ± SD for n = 3 experiments) of HIV-1 IN mutant concerted integration activities normalized to WT, which was set at 100%. Asterisks highlight significant differences from the WT as defined in Figure 2.
Figure 3. Concerted vDNA integration activities of HIV-1 IN proteins. (A) The agarose gel image highlights migration positions of the pre-processed 32-bp vDNA substrate, supercoiled (s.c.) and open circular (o.c.) forms of pGEM-3 tDNA, as well as products of half-site and concerted vDNA integration. The reactions loaded in lanes 1 and 18 omitted IN protein; LEDGF/p75 was included in each set of reactions as indicated. (B) Results (average ± SD for n = 3 experiments) of HIV-1 IN mutant concerted integration activities normalized to WT, which was set at 100%. Asterisks highlight significant differences from the WT as defined in Figure 2.CC BY-NC · PubMed Central
Figure 4. Nucleotide preferences at sites of WT and IN mutant enzyme integration in vitro. Data is presented using WebLogo (33), wherein the height of each base logo within a given stack is proportional to the frequency of the corresponding nucleotide within the alignment, and the height of each stack of logos reflects the level of conservation at each position. Arrows denote the boundaries of 5-bp duplicated tDNA sequence. Asterisks denote statistically significant differences from the WT signature at the indicated nucleotide position (*P < 0.05; **P < 0.01; ***P < 10−5).
Figure 4. Nucleotide preferences at sites of WT and IN mutant enzyme integration in vitro. Data is presented using WebLogo (33), wherein the height of each base logo within a given stack is proportional to the frequency of the corresponding nucleotide within the alignment, and the height of each stack of logos reflects the level of conservation at each position. Arrows denote the boundaries of 5-bp duplicated tDNA sequence. Asterisks denote statistically significant differences from the WT signature at the indicated nucleotide position (*P < 0.05; **P < 0.01; ***P < 10−5).CC BY-NC · PubMed Central
Figure 5. Dinucleotide content analysis of WT HIV-1 IN in vitro concerted integration sites. (A) Dinucleotide bin positions are defined using the WebLogo consensus sequence for WT HIV-1 IN from the upper left panel in Figure 4 as guide. (B) Frequencies of RY and YR (left y-axis) and RR and YY content (right y-axis) at and surrounding the integration sites. (C) Graph showing the frequency of rigid versus flexible dinucleotides (% RY/(YR+YY/RR)) for WT HIV-1 IN across the integration site. The dashed lines (B) indicate the expected frequency of RY and YR (23.9%) or RR/YY (52.2%) dinucleotides and (C) the expected RY/(YR+YY/RR) frequency (31.4%). P-values (B) reflect the significance of the change in dinucleotide preference of WT HIV-1 IN versus randomly generated sequences and (C) significance of the change in preference of rigid dinucleotides over flexible dinucleotides. *P ≤ 0.05; **P ≤ 0.005.
Figure 5. Dinucleotide content analysis of WT HIV-1 IN in vitro concerted integration sites. (A) Dinucleotide bin positions are defined using the WebLogo consensus sequence for WT HIV-1 IN from the upper left panel in Figure 4 as guide. (B) Frequencies of RY and YR (left y-axis) and RR and YY content (right y-axis) at and surrounding the integration sites. (C) Graph showing the frequency of rigid versus flexible dinucleotides (% RY/(YR+YY/RR)) for WT HIV-1 IN across the integration site. The dashed lines (B) indicate the expected frequency of RY and YR (23.9%) or RR/YY (52.2%) dinucleotides and (C) the expected RY/(YR+YY/RR) frequency (31.4%). P-values (B) reflect the significance of the change in dinucleotide preference of WT HIV-1 IN versus randomly generated sequences and (C) significance of the change in preference of rigid dinucleotides over flexible dinucleotides. *P ≤ 0.05; **P ≤ 0.005.CC BY-NC · PubMed Central
Figure 6. Single-cycle HIV-1 infections. The infectivity of each indicated IN mutant virus is normalized to the level of WT virus infection, which was set to 100%. Results are average ± SD for two independent experiments, each performed in duplicate. Asterisks denote statistically relevant differences from the WT (*P < 0.05; **P < 0.01; ***P < 10−4). Residue 232, which is a known polymorphic site in IN (40), is Asn and Asp in our HIV-1HXB2-based bacterial and HIV-1NL4-3-based viral expression vectors, respectively.
Figure 6. Single-cycle HIV-1 infections. The infectivity of each indicated IN mutant virus is normalized to the level of WT virus infection, which was set to 100%. Results are average ± SD for two independent experiments, each performed in duplicate. Asterisks denote statistically relevant differences from the WT (*P < 0.05; **P < 0.01; ***P < 10−4). Residue 232, which is a known polymorphic site in IN (40), is Asn and Asp in our HIV-1HXB2-based bacterial and HIV-1NL4-3-based viral expression vectors, respectively.CC BY-NC · PubMed Central
Figure 7. Integration site preferences of WT and IN mutant viruses. The legend to Figure 4 explains the heights of the different base logos within a stack and the heights of the different stacks along the x-axis. Asterisks denote statistically significant differences from the WT signature at the indicated nucleotide position (*P < 0.05; **P < 0.01; ***P < 10−5).
Figure 7. Integration site preferences of WT and IN mutant viruses. The legend to Figure 4 explains the heights of the different base logos within a stack and the heights of the different stacks along the x-axis. Asterisks denote statistically significant differences from the WT signature at the indicated nucleotide position (*P < 0.05; **P < 0.01; ***P < 10−5).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Foley, 2013, HIV Sequence Compendium 2013

Cited by

See all 59

Metadata

Authors
Serrao, E., Krishnan, L., Shun, M.-C., Li, X., Cherepanov, P., Engelman, A., & Maertens, G. N.
Affiliations
Harvard University (US)
Corresponding author
Maertens, Goedele N.
Venue
Nucleic Acids Research
Published
2014-02-11
Volume
42
Issue
8
Pages
5164-5176
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2118596104
Cited by
59
References
67
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 6 · 2020: 3 · 2019: 6 · 2018: 3 · 2017: 7 · 2016: 8 · 2015: 12 · 2014: 4
FWCI
4.61
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
Funders
  • Imperial College London
  • National Institutes of Health
  • Medical Research Council (G0900116)
  • National Institute of Allergy and Infectious Diseases (AI039394, R01AI070042, AI070042, R37AI039394, T32AI007245)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
HIV-1 integrase, nucleotide preference, integration site selection, integrase mutations, retroviral integration
MeSH terms
Amino Acid Sequence, Cell Line, DNA, Mutation, Nucleotides, Protein Binding, HIV-1, Spumavirus, Sequence Alignment, Virus Integration, Sequence Analysis, DNA, Integrases, HIV Integrase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.